The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Cardiac remodeling and failure
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673
Tumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Research works printed but not linked: 114
- Lloyd-Jones, 2002, Lifetime risk for developing congestive heart failure: the Framingham Heart Study, Circulation, 106, 3068, 10.1161/01.CIR.0000039105.49749.6F · DOI · Paper page
- Zeltsman, 2002, Surgical management of heart failure: an overview, Annu Rev Med, 53, 383, 10.1146/annurev.med.53.082901.104101 · DOI
- Braunwald, 2000, Congestive heart failure: fifty years of progress, Circulation, 102, IV14
- Mann, 1999, Mechanisms and models in heart failure: a combinatorial approach, Circulation, 100, 999, 10.1161/01.CIR.100.9.999 · DOI · Paper page
- Cohn, 1997, Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research, Circulation, 95, 766, 10.1161/01.CIR.95.4.766 · DOI · Paper page
- Zile, 2002, New concepts in diastolic dysfunction and diastolic heart failure: Part II. Causal mechanisms and treatment, Circulation, 105, 1503, 10.1161/hc1202.105290 · DOI · Paper page
- Zile, 2002, New concepts in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurements of diastolic function, Circulation, 105, 1387, 10.1161/hc1102.105289 · DOI · Paper page
- Hoshijima, 2002, Mixed signals in heart failure: cancer rules, J Clin Invest, 109, 849, 10.1172/JCI0215380 · DOI
- Swynghedauw, 1999, Molecular mechanisms of myocardial remodeling, Physiol Rev, 79, 215, 10.1152/physrev.1999.79.1.215 · DOI · Paper page
- Cohn, 2000, Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling, J Am Coll Cardiol, 35, 569, 10.1016/S0735-1097(99)00630-0 · DOI · Paper page
- Udelson, 2002, Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction, J Card Fail, 8, S465, 10.1054/jcaf.2002.129289 · DOI
- Spotnitz, 2000, Macro design, structure, and mechanics of the left ventricle, J Thorac Cardiovasc Surg, 119, 1053, 10.1016/S0022-5223(00)70106-1 · DOI
- Carabello, 2002, Concentric versus eccentric remodeling, J Card Fail, 8, S258, 10.1054/jcaf.2002.129250 · DOI
- Linzbach, 1960, Heart failure from the point of view of quantitative anatomy, Am J Cardiol, 5, 370, 10.1016/0002-9149(60)90084-9 · DOI · Paper page
- Plante, 2003, Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats, J Card Fail, 9, 128, 10.1054/jcaf.2003.17 · doi:10.1054/jcaf.2003.17
- Brower, 2001, Contribution of ventricular remodeling to pathogenesis of heart failure in rats, Am J Physiol Heart Circ Physiol, 280, H674, 10.1152/ajpheart.2001.280.2.H674 · DOI
- Pfeffer, 1987, Ventricular enlargement and reduced survival after myocardial infarction, Circulation, 75, IV93
- St John, 1997, Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial, Circulation, 96, 3294, 10.1161/01.CIR.96.10.3294 · DOI · Paper page
- de Kam, 2002, Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data, Eur Heart J, 23, 536, 10.1053/euhj.2001.2820 · doi:10.1053/euhj.2001.2820
- Gaudron, 1993, Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors, Circulation, 87, 755, 10.1161/01.CIR.87.3.755 · DOI · Paper page
- Dickstein, 1997, Heart reduction surgery: an analysis of the impact on cardiac function, J Thorac Cardiovasc Surg, 113, 1032, 10.1016/S0022-5223(97)70288-5 · doi:10.1016/s0022-5223(97)70288-5
- Bolognese, 2002, Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications, Circulation, 106, 2351, 10.1161/01.CIR.0000036014.90197.FA · DOI · Paper page
- Houser, 2003, Is depressed myocyte contractility centrally involved in heart failure?, Circ Res, 92, 350, 10.1161/01.RES.0000060027.40275.A6 · DOI · Paper page
- Davies, 1995, Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure, Circulation, 92, 2540, 10.1161/01.CIR.92.9.2540 · DOI · Paper page
- Harding, 1995, Abnormalities of the myocytes in ischaemic cardiomyopathy, Eur Heart J, 16, 74, 10.1093/eurheartj/16.suppl_I.74 · doi:10.1093/eurheartj/16.suppl_i.74
- Anand, 1997, Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction, Circulation, 96, 3974, 10.1161/01.CIR.96.11.3974 · DOI
- Baicu, 2003, Changes in extracellular collagen matrix alter myocardial systolic performance, Am J Physiol Heart Circ Physiol, 284, H122, 10.1152/ajpheart.00233.2002 · DOI
- Sugden, 1999, Signaling in myocardial hypertrophy: life after calcineurin?, Circ Res, 84, 633, 10.1161/01.RES.84.6.633 · DOI · Paper page
- Weber, 1989, Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease, Am J Hypertens, 2, 931, 10.1093/ajh/2.12.931 · DOI
- Litwin, 1991, Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function, Circulation, 84, 1819, 10.1161/01.CIR.84.4.1819 · DOI
- Liao, 2002, Shedding growth factors in cardiac hypertrophy, Nat Med, 8, 20, 10.1038/nm0102-20 · doi:10.1038/nm0102-20
- Asakura, 2002, Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy, Nat Med, 8, 35, 10.1038/nm0102-35 · DOI · Paper page
- Terracio, 1991, Expression of collagen binding integrins during cardiac development and hypertrophy, Circ Res, 68, 734, 10.1161/01.RES.68.3.734 · DOI · Paper page
- Ross, 2001, Integrins and the myocardium, Circ Res, 88, 1112, 10.1161/hh1101.091862 · DOI · Paper page
- Gerdes, 1995, Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure, J Mol Cell Cardiol, 27, 849, 10.1016/0022-2828(95)90000-4 · DOI · Paper page
- Gerdes, 2002, Cardiac myocyte remodeling in hypertrophy and progression to failure, J Card Fail, 8, S264, 10.1054/jcaf.2002.129280 · DOI
- Spinale, 1993, Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload, J Thorac Cardiovasc Surg, 106, 1147, 10.1016/S0022-5223(19)33992-3 · DOI
- Tamura, 1998, Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat, J Mol Cell Cardiol, 30, 2175, 10.1006/jmcc.1998.0775 · DOI
- Onodera, 1998, Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension, Hypertension, 32, 753, 10.1161/01.HYP.32.4.753 · DOI
- Spotnitz, 1974, Cellular basis for volume related wall thickness changes in the rat left ventricle, J Mol Cell Cardiol, 6, 317, 10.1016/0022-2828(74)90074-1 · DOI
- Kang, 2000, Apoptosis and heart failure: a critical review of the literature, Circ Res, 86, 1107, 10.1161/01.RES.86.11.1107 · DOI · Paper page
- Li, 1997, Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat, Am J Physiol, 272, H2313
- Mani, 2003, Myocyte apoptosis: programming ventricular remodeling, J Am Coll Cardiol, 41, 761, 10.1016/S0735-1097(02)02958-3 · DOI
- Condorelli, 1999, Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat, Circulation, 99, 3071, 10.1161/01.CIR.99.23.3071 · DOI · Paper page
- Yue, 1998, Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol, Circ Res, 82, 166, 10.1161/01.RES.82.2.166 · DOI · Paper page
- Schulze-Osthoff, 1998, Apoptosis signaling by death receptors, Eur J Biochem, 254, 439, 10.1046/j.1432-1327.1998.2540439.x · DOI · Paper page
- Abbate, 2003, Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure, J Am Coll Cardiol, 41, 753, 10.1016/S0735-1097(02)02959-5 · DOI · Paper page
- Schaper, 1999, The role of apoptosis in dilated cardiomyopathy, Herz, 24, 219, 10.1007/BF03044964 · DOI
- Saraste, 1999, Cardiomyocyte apoptosis and progression of heart failure to transplantation, Eur J Clin Invest, 29, 380, 10.1046/j.1365-2362.1999.00481.x · DOI · Paper page
- Chatterjee, 1999, Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure, Circulation, 106, 1212
- Ren, 1999, Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease, J Mol Cell Cardiol, 31, 2049, 10.1006/jmcc.1999.1036 · DOI · Paper page
- Li, 1997, Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy, J Clin Invest, 100, 1991, 10.1172/JCI119730 · DOI · Paper page
- Lee, 1999, Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy, Endocrinology, 140, 4831, 10.1210/en.140.10.4831 · doi:10.1210/en.140.10.4831
- Ding, 2000, Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure, Circulation, 101, 2854, 10.1161/01.CIR.101.24.2854 · DOI
- Nadal-Ginard, 2003, Myocyte death, growth, and regeneration in cardiac hypertrophy and failure, Circ Res, 92, 139, 10.1161/01.RES.0000053618.86362.DF · DOI · Paper page
- Nadal-Ginard, 2003, A matter of life and death: cardiac myocyte apoptosis and regeneration, J Clin Invest, 111, 1457, 10.1172/JCI200318611 · DOI
- Anversa, 2002, Myocyte renewal and ventricular remodeling, Nature, 415, 240, 10.1038/415240a · DOI · Paper page
- Soonpaa, 1998, Survey of studies examining mammalian cardiomyocyte DNA synthesis, Circ Res, 83, 15, 10.1161/01.RES.83.1.15 · DOI · Paper page
- Anversa, 2002, Cardiac chimerism: methods matter, Circulation, 106, e129, 10.1161/01.CIR.0000035926.40150.D0 · doi:10.1161/01.cir.0000035926.40150.d0
- Anversa, 1998, Ventricular myocytes are not terminally differentiated in the adult mammalian heart, Circ Res, 83, 1, 10.1161/01.RES.83.1.1 · DOI · Paper page
- Beltrami, 2001, Evidence that human cardiac myocytes divide after myocardial infarction, N Engl J Med, 344, 1750, 10.1056/NEJM200106073442303 · DOI · Paper page
- Kajstura, 1998, Myocyte proliferation in end-stage cardiac failure in humans, Proc Natl Acad Sci U S A, 95, 8801, 10.1073/pnas.95.15.8801 · DOI · Paper page
- Orlic, 2002, Stem cells for myocardial regeneration, Circ Res, 91, 1092, 10.1161/01.RES.0000046045.00846.B0 · DOI · Paper page
- Orlic, 2001, Transplanted adult bone marrow cells repair myocardial infarcts in mice, Ann N Y Acad Sci, 938, 221, 10.1111/j.1749-6632.2001.tb03592.x · DOI · Paper page
- Orlic, 2001, Bone marrow cells regenerate infarcted myocardium, Nature, 410, 701, 10.1038/35070587 · DOI · Paper page
- Orlic, 2001, Mobilized bone marrow cells repair the infarcted heart, improving function and survival, Proc Natl Acad Sci U S A, 98, 10344, 10.1073/pnas.181177898 · DOI · Paper page
- Quaini, 2002, Chimerism of the transplanted heart, N Engl J Med, 346, 5, 10.1056/NEJMoa012081 · DOI · Paper page
- Laflamme, 2002, Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts, Circ Res, 90, 634, 10.1161/01.RES.0000014822.62629.EB · DOI · Paper page
- Deb, 2003, Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients, Circulation, 107, 1247, 10.1161/01.CIR.0000061910.39145.F0 · DOI · Paper page
- Nadal-Ginard, 2002, Chimera or not chimera?, Circ Res, 90, E72, 10.1161/01.RES.0000019363.77779.1D · doi:10.1161/01.res.0000019363.77779.1d
- Patten, 2000, Ventricular remodeling and the renin angiotensin aldosterone system, Congest Heart Fail, 6, 187, 10.1111/j.1527-5299.2000.80159.x · DOI
- Sadoshima, 1993, Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro, Cell, 75, 977, 10.1016/0092-8674(93)90541-W · DOI · Paper page
- Sadoshima, 1993, Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype, Circ Res, 73, 413, 10.1161/01.RES.73.3.413 · DOI · Paper page
- Walther, 2002, Left ventricular reverse remodeling after surgical therapy for aortic stenosis: correlation to renin–angiotensin system gene expression, Circulation, 106, 123
- Liu, 2001, The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure, Can J Cardiol, 17, 5E
- Labinjoh, 2001, Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition, J Am Coll Cardiol, 38, 1402, 10.1016/S0735-1097(01)01562-5 · DOI
- Witherow, 2001, Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure, Circulation, 104, 2177, 10.1161/hc4301.098252 · DOI
- Jong, 2002, Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials, J Am Coll Cardiol, 39, 463, 10.1016/S0735-1097(01)01775-2 · DOI · Paper page
- Silvestre, 1998, Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation, J Biol Chem, 273, 4883, 10.1074/jbc.273.9.4883 · DOI · Paper page
- Weber, 2001, Aldosterone in congestive heart failure, N Engl J Med, 345, 1689, 10.1056/NEJMra000050 · DOI · Paper page
- Weber, 1997, Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation, Circulation, 96, 4065, 10.1161/01.CIR.96.11.4065 · DOI · Paper page
- Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 · DOI · Paper page
- Soberman, 2002, Aldosterone antagonists in congestive heart failure, Curr Opin Investig Drugs, 3, 1024
- Zannad, 2000, Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators, Circulation, 102, 2700, 10.1161/01.CIR.102.22.2700 · DOI · Paper page
- Swedberg, 1984, Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure, Am J Cardiol, 54, 783, 10.1016/S0002-9149(84)80208-8 · DOI · Paper page
- Port, 2001, Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure, J Mol Cell Cardiol, 33, 887, 10.1006/jmcc.2001.1358 · DOI · Paper page
- Mann, 1992, Adrenergic effects on the biology of the adult mammalian cardiocyte, Circulation, 85, 790, 10.1161/01.CIR.85.2.790 · DOI · Paper page
- Engelhardt, 1999, Progressive hypertrophy and heart failure in beta 1-adrenergic receptor transgenic mice, Proc Natl Acad Sci U S A, 96, 7059, 10.1073/pnas.96.12.7059 · DOI · Paper page
- Francis, 1990, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD), Circulation, 82, 1724, 10.1161/01.CIR.82.5.1724 · DOI · Paper page
- Bristow, 2000, Mechanistic and clinical rationales for using beta-blockers in heart failure, J Card Fail, 6, 8
- Eichhorn, 1996, Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure, Circulation, 94, 2285, 10.1161/01.CIR.94.9.2285 · DOI · Paper page
- Hall, 1995, Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade, J Am Coll Cardiol, 25, 1154, 10.1016/0735-1097(94)00543-Y · DOI · Paper page
- Mann, 2002, Inflammatory mediators and the failing heart: past, present, and the foreseeable future, Circ Res, 91, 988, 10.1161/01.RES.0000043825.01705.1B · DOI · Paper page
- Seta, 1996, Basic mechanisms in heart failure: the cytokine hypothesis, J Card Fail, 2, 243, 10.1016/S1071-9164(96)80047-9 · DOI · Paper page
- Mann, 1996, The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines, J Card Fail, 2, S165, 10.1016/S1071-9164(96)80073-X · DOI
- Kapadia, 1995, Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration, J Clin Invest, 96, 1042, 10.1172/JCI118090 · DOI · Paper page
- Comstock, 1998, LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response, J Mol Cell Cardiol, 30, 2761, 10.1006/jmcc.1998.0851 · DOI
- Kumar, 1996, Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum, J Exp Med, 183, 949, 10.1084/jem.183.3.949 · DOI · Paper page
- Yokoyama, 1997, Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes, Circulation, 95, 1247, 10.1161/01.CIR.95.5.1247 · DOI · Paper page
- Torre-Amione, 1995, Expression and functional significance of tumor necrosis factor receptors in human myocardium, Circulation, 92, 1487, 10.1161/01.CIR.92.6.1487 · DOI · Paper page
- Torre-Amione, 1996, Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart, Circulation, 93, 704, 10.1161/01.CIR.93.4.704 · DOI · Paper page
- Kapadia S, Dibbs Z, Kurrelmeyer K, Kalra D, Seta Y, Wang F, Bozkurt B, Oral H, Sivasubramanian N, Mann DL. The role of cytokines in the failing human heart. Cardiol Clin 1998; 16(4):645-56, viii. · DOI
- Satoh, 1999, Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy, Circulation, 99, 3260, 10.1161/01.CIR.99.25.3260 · DOI
- Satoh, 2000, Expression of tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human myocarditis, J Am Coll Cardiol, 36, 1288, 10.1016/S0735-1097(00)00827-5 · DOI
- Oral, 2003, Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation, Circulation, 107, 831, 10.1161/01.CIR.0000049745.38594.6D · DOI
- Deswal, 2001, Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST), Circulation, 103, 2055, 10.1161/01.CIR.103.16.2055 · DOI · Paper page
- Vasan, 2003, Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study, Circulation, 107, 1486, 10.1161/01.CIR.0000057810.48709.F6 · DOI · Paper page
- Bryant, 1998, Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha, Circulation, 97, 1375, 10.1161/01.CIR.97.14.1375 · DOI · Paper page
- Sivasubramanian, 2001, Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor, Circulation, 104, 826, 10.1161/hc3401.093154 · DOI · Paper page
- Franco, 1999, Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha, Circulation, 99, 448, 10.1161/01.CIR.99.3.448 · DOI
- Bozkurt, 1998, Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats, Circulation, 97, 1382, 10.1161/01.CIR.97.14.1382 · DOI · Paper page
- Bradham, 2002, TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling, Am J Physiol Heart Circ Physiol, 282, H1288, 10.1152/ajpheart.00526.2001 · DOI
- Li, 2000, Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy, Proc Natl Acad Sci U S A, 97, 12746, 10.1073/pnas.97.23.12746 · DOI · Paper page
- Krum, 2002, Tumor necrosis factor-alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): unsuccessful, to be specific, J Card Fail, 8, 365, 10.1054/jcaf.2002.130237 · DOI
Cited by
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Verma, S., & McMurray, J. J. V. (2018) · Diabetologia · doi:10.1007/s00125-018-4670-7 · Cited by 999
Self-citationAbel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Landa, N., Miller, L., Feinberg, M. S., Holbova, R., Shachar, M., Freeman, I., Cohen, S., & Leor, J. (2008) · Circulation · doi:10.1161/circulationaha.107.727420 · Cited by 449
Segura, A. M., Frazier, O. H., & Buja, L. M. (2014) · Heart Failure Reviews · doi:10.1007/s10741-012-9365-4 · Cited by 371
Metadata
- Authors
- Fedak, P. W. M., Verma, S., Weisel, R. D., & Li, R.-K.
- Venue
- Cardiovascular Pathology
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 14
- Issue
- 1
- Pages
- 1-11
- ISSN
- 1054-8807 (ISSN-L)
- OpenAlex
- W2148001793
- Cited by
- 214
- References
- 17
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiac remodeling and failure. https://app.cochat.ai/papers/10.1016/j.carpath.2004.12.002
- The paper
- Fedak, P. W. M., Verma, S., Weisel, R. D., & Li, R.-K. (2005). Cardiac remodeling and failure. Cardiovascular Pathology. https://doi.org/10.1016/j.carpath.2004.12.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.